UBS Group’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $170K | Sell |
|
|||||
|
2025
Q2 | $201K | Sell |
|
|||||
|
2025
Q1 | $169K | Buy |
|
|||||
|
2024
Q4 | $177K | Buy |
|
|||||
|
2024
Q3 | $111K | Buy |
|
|||||
|
2024
Q2 | $44.2K | Sell |
|
|||||
|
2024
Q1 | $137K | Sell |
|
|||||
|
2023
Q4 | $151K | Buy |
|
|||||
|
2023
Q3 | $52.2K | Sell |
|
|||||
|
2023
Q2 | $86.8K | Buy |
|
|||||
|
2023
Q1 | $47.5K | Buy |
|
|||||
|
2022
Q4 | $32.2K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $45K | Sell |
|
|||||
|
2021
Q4 | $158K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $28K | Sell |
|
|||||
|
2020
Q4 | $46K | Buy |
|